Global Artificial Intelligence Drug Development Market Growth (Status and Outlook) 2024-2030
According to our LPI (LP Information) latest study, the global Artificial Intelligence Drug Development market size was valued at US$ million in 2023. With growing demand in downstream market, the ... もっと見る
日本語のページは自動翻訳を利用し作成しています。
SummaryAccording to our LPI (LP Information) latest study, the global Artificial Intelligence Drug Development market size was valued at US$ million in 2023. With growing demand in downstream market, the Artificial Intelligence Drug Development is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.The research report highlights the growth potential of the global Artificial Intelligence Drug Development market. Artificial Intelligence Drug Development are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Artificial Intelligence Drug Development. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Artificial Intelligence Drug Development market. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Key Features: The report on Artificial Intelligence Drug Development market reflects various aspects and provide valuable insights into the industry. Market Size and Growth: The research report provide an overview of the current size and growth of the Artificial Intelligence Drug Development market. It may include historical data, market segmentation by Type (e.g., Drug Design, Drug Synthesis), and regional breakdowns. Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Artificial Intelligence Drug Development market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs. Competitive Landscape: The research report provides analysis of the competitive landscape within the Artificial Intelligence Drug Development market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market. Technological Developments: The research report can delve into the latest technological developments in the Artificial Intelligence Drug Development industry. This include advancements in Artificial Intelligence Drug Development technology, Artificial Intelligence Drug Development new entrants, Artificial Intelligence Drug Development new investment, and other innovations that are shaping the future of Artificial Intelligence Drug Development. Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Artificial Intelligence Drug Development market. It includes factors influencing customer ' purchasing decisions, preferences for Artificial Intelligence Drug Development product. Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Artificial Intelligence Drug Development market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Artificial Intelligence Drug Development market. The report also evaluates the effectiveness of these policies in driving market growth. Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Artificial Intelligence Drug Development market. Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Artificial Intelligence Drug Development industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments. Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Artificial Intelligence Drug Development market. Market Segmentation: Artificial Intelligence Drug Development market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value. Segmentation by type Drug Design Drug Synthesis Other Segmentation by application Tumor Nervous System Other This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Insilico Medicine Cyclica XtalPi Inc. Exscientia Limited AiCure, LLC Atomwise Biovista Inc. Breg,Inc. Numerate Cloud Pharmaceuticals IBM NuMedii BenevolentAI Lam Therapeutics Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Artificial Intelligence Drug Development Market Size 2019-2030 2.1.2 Artificial Intelligence Drug Development Market Size CAGR by Region 2019 VS 2023 VS 2030 2.2 Artificial Intelligence Drug Development Segment by Type 2.2.1 Drug Design 2.2.2 Drug Synthesis 2.2.3 Other 2.3 Artificial Intelligence Drug Development Market Size by Type 2.3.1 Artificial Intelligence Drug Development Market Size CAGR by Type (2019 VS 2023 VS 2030) 2.3.2 Global Artificial Intelligence Drug Development Market Size Market Share by Type (2019-2024) 2.4 Artificial Intelligence Drug Development Segment by Application 2.4.1 Tumor 2.4.2 Nervous System 2.4.3 Other 2.5 Artificial Intelligence Drug Development Market Size by Application 2.5.1 Artificial Intelligence Drug Development Market Size CAGR by Application (2019 VS 2023 VS 2030) 2.5.2 Global Artificial Intelligence Drug Development Market Size Market Share by Application (2019-2024) 3 Artificial Intelligence Drug Development Market Size by Player 3.1 Artificial Intelligence Drug Development Market Size Market Share by Players 3.1.1 Global Artificial Intelligence Drug Development Revenue by Players (2019-2024) 3.1.2 Global Artificial Intelligence Drug Development Revenue Market Share by Players (2019-2024) 3.2 Global Artificial Intelligence Drug Development Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Artificial Intelligence Drug Development by Regions 4.1 Artificial Intelligence Drug Development Market Size by Regions (2019-2024) 4.2 Americas Artificial Intelligence Drug Development Market Size Growth (2019-2024) 4.3 APAC Artificial Intelligence Drug Development Market Size Growth (2019-2024) 4.4 Europe Artificial Intelligence Drug Development Market Size Growth (2019-2024) 4.5 Middle East & Africa Artificial Intelligence Drug Development Market Size Growth (2019-2024) 5 Americas 5.1 Americas Artificial Intelligence Drug Development Market Size by Country (2019-2024) 5.2 Americas Artificial Intelligence Drug Development Market Size by Type (2019-2024) 5.3 Americas Artificial Intelligence Drug Development Market Size by Application (2019-2024) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Artificial Intelligence Drug Development Market Size by Region (2019-2024) 6.2 APAC Artificial Intelligence Drug Development Market Size by Type (2019-2024) 6.3 APAC Artificial Intelligence Drug Development Market Size by Application (2019-2024) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Artificial Intelligence Drug Development by Country (2019-2024) 7.2 Europe Artificial Intelligence Drug Development Market Size by Type (2019-2024) 7.3 Europe Artificial Intelligence Drug Development Market Size by Application (2019-2024) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Artificial Intelligence Drug Development by Region (2019-2024) 8.2 Middle East & Africa Artificial Intelligence Drug Development Market Size by Type (2019-2024) 8.3 Middle East & Africa Artificial Intelligence Drug Development Market Size by Application (2019-2024) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Artificial Intelligence Drug Development Market Forecast 10.1 Global Artificial Intelligence Drug Development Forecast by Regions (2025-2030) 10.1.1 Global Artificial Intelligence Drug Development Forecast by Regions (2025-2030) 10.1.2 Americas Artificial Intelligence Drug Development Forecast 10.1.3 APAC Artificial Intelligence Drug Development Forecast 10.1.4 Europe Artificial Intelligence Drug Development Forecast 10.1.5 Middle East & Africa Artificial Intelligence Drug Development Forecast 10.2 Americas Artificial Intelligence Drug Development Forecast by Country (2025-2030) 10.2.1 United States Artificial Intelligence Drug Development Market Forecast 10.2.2 Canada Artificial Intelligence Drug Development Market Forecast 10.2.3 Mexico Artificial Intelligence Drug Development Market Forecast 10.2.4 Brazil Artificial Intelligence Drug Development Market Forecast 10.3 APAC Artificial Intelligence Drug Development Forecast by Region (2025-2030) 10.3.1 China Artificial Intelligence Drug Development Market Forecast 10.3.2 Japan Artificial Intelligence Drug Development Market Forecast 10.3.3 Korea Artificial Intelligence Drug Development Market Forecast 10.3.4 Southeast Asia Artificial Intelligence Drug Development Market Forecast 10.3.5 India Artificial Intelligence Drug Development Market Forecast 10.3.6 Australia Artificial Intelligence Drug Development Market Forecast 10.4 Europe Artificial Intelligence Drug Development Forecast by Country (2025-2030) 10.4.1 Germany Artificial Intelligence Drug Development Market Forecast 10.4.2 France Artificial Intelligence Drug Development Market Forecast 10.4.3 UK Artificial Intelligence Drug Development Market Forecast 10.4.4 Italy Artificial Intelligence Drug Development Market Forecast 10.4.5 Russia Artificial Intelligence Drug Development Market Forecast 10.5 Middle East & Africa Artificial Intelligence Drug Development Forecast by Region (2025-2030) 10.5.1 Egypt Artificial Intelligence Drug Development Market Forecast 10.5.2 South Africa Artificial Intelligence Drug Development Market Forecast 10.5.3 Israel Artificial Intelligence Drug Development Market Forecast 10.5.4 Turkey Artificial Intelligence Drug Development Market Forecast 10.5.5 GCC Countries Artificial Intelligence Drug Development Market Forecast 10.6 Global Artificial Intelligence Drug Development Forecast by Type (2025-2030) 10.7 Global Artificial Intelligence Drug Development Forecast by Application (2025-2030) 11 Key Players Analysis 11.1 Insilico Medicine 11.1.1 Insilico Medicine Company Information 11.1.2 Insilico Medicine Artificial Intelligence Drug Development Product Offered 11.1.3 Insilico Medicine Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024) 11.1.4 Insilico Medicine Main Business Overview 11.1.5 Insilico Medicine Latest Developments 11.2 Cyclica 11.2.1 Cyclica Company Information 11.2.2 Cyclica Artificial Intelligence Drug Development Product Offered 11.2.3 Cyclica Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024) 11.2.4 Cyclica Main Business Overview 11.2.5 Cyclica Latest Developments 11.3 XtalPi Inc. 11.3.1 XtalPi Inc. Company Information 11.3.2 XtalPi Inc. Artificial Intelligence Drug Development Product Offered 11.3.3 XtalPi Inc. Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024) 11.3.4 XtalPi Inc. Main Business Overview 11.3.5 XtalPi Inc. Latest Developments 11.4 Exscientia Limited 11.4.1 Exscientia Limited Company Information 11.4.2 Exscientia Limited Artificial Intelligence Drug Development Product Offered 11.4.3 Exscientia Limited Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024) 11.4.4 Exscientia Limited Main Business Overview 11.4.5 Exscientia Limited Latest Developments 11.5 AiCure, LLC 11.5.1 AiCure, LLC Company Information 11.5.2 AiCure, LLC Artificial Intelligence Drug Development Product Offered 11.5.3 AiCure, LLC Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024) 11.5.4 AiCure, LLC Main Business Overview 11.5.5 AiCure, LLC Latest Developments 11.6 Atomwise 11.6.1 Atomwise Company Information 11.6.2 Atomwise Artificial Intelligence Drug Development Product Offered 11.6.3 Atomwise Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024) 11.6.4 Atomwise Main Business Overview 11.6.5 Atomwise Latest Developments 11.7 Biovista Inc. 11.7.1 Biovista Inc. Company Information 11.7.2 Biovista Inc. Artificial Intelligence Drug Development Product Offered 11.7.3 Biovista Inc. Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024) 11.7.4 Biovista Inc. Main Business Overview 11.7.5 Biovista Inc. Latest Developments 11.8 Breg,Inc. 11.8.1 Breg,Inc. Company Information 11.8.2 Breg,Inc. Artificial Intelligence Drug Development Product Offered 11.8.3 Breg,Inc. Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024) 11.8.4 Breg,Inc. Main Business Overview 11.8.5 Breg,Inc. Latest Developments 11.9 Numerate 11.9.1 Numerate Company Information 11.9.2 Numerate Artificial Intelligence Drug Development Product Offered 11.9.3 Numerate Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024) 11.9.4 Numerate Main Business Overview 11.9.5 Numerate Latest Developments 11.10 Cloud Pharmaceuticals 11.10.1 Cloud Pharmaceuticals Company Information 11.10.2 Cloud Pharmaceuticals Artificial Intelligence Drug Development Product Offered 11.10.3 Cloud Pharmaceuticals Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024) 11.10.4 Cloud Pharmaceuticals Main Business Overview 11.10.5 Cloud Pharmaceuticals Latest Developments 11.11 IBM 11.11.1 IBM Company Information 11.11.2 IBM Artificial Intelligence Drug Development Product Offered 11.11.3 IBM Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024) 11.11.4 IBM Main Business Overview 11.11.5 IBM Latest Developments 11.12 NuMedii 11.12.1 NuMedii Company Information 11.12.2 NuMedii Artificial Intelligence Drug Development Product Offered 11.12.3 NuMedii Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024) 11.12.4 NuMedii Main Business Overview 11.12.5 NuMedii Latest Developments 11.13 BenevolentAI 11.13.1 BenevolentAI Company Information 11.13.2 BenevolentAI Artificial Intelligence Drug Development Product Offered 11.13.3 BenevolentAI Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024) 11.13.4 BenevolentAI Main Business Overview 11.13.5 BenevolentAI Latest Developments 11.14 Lam Therapeutics 11.14.1 Lam Therapeutics Company Information 11.14.2 Lam Therapeutics Artificial Intelligence Drug Development Product Offered 11.14.3 Lam Therapeutics Artificial Intelligence Drug Development Revenue, Gross Margin and Market Share (2019-2024) 11.14.4 Lam Therapeutics Main Business Overview 11.14.5 Lam Therapeutics Latest Developments 12 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(金融)の最新刊レポート
LP Information 社の最新刊レポート本レポートと同じKEY WORD(intelligence)の最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/10/09 10:26 149.25 円 164.26 円 198.27 円 |